Ackermans & Van Haaren NV - ACKB.BR

ACKB.BR Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ACKB.BR	-0.1	2.1	-3.0	-0.2	9.1	21.7	8.6	29.6	80.8	543.6
S&P 500	-0.5	1.2	2.9	5.4	13.0	21.8	31.6	85.9	198.9	34104.6

Compare ACKB.BR with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ACKB.BR
name	Ackermans & Van Haaren NV
price	187.6
changes percentage	-0.1065
change	-0.2
day low	187.2
day high	188.5
year high	198.3
year low	154
market cap	6137650856
price avg 50	189.482
price avg 200	178.8325
exchange	EURONEXT
volume	20291
avg volume	24625
open	188.1
previous close	187.8
eps	13.08
pe	14.34
earnings announcement	2025-02-28T10:59:00.000+0000
shares outstanding	32716689
timestamp	2025-01-31 16:35:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 38.7%

Overall Quarterly Financial Health: 53.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	5221553000	4401419000	18.63
gross profit	1883278000	372180000	406.01
gross profit ratio	0.36	0.08	326.53
research and development expenses	0	108000	-100.00
operating expenses	1455148000	8408000	17206.71
interest income	36959000	17619000	109.77
interest expense	58544000	57412000	1.97
ebitda	1053415000	1062713000	-0.87
ebitdaratio	0.2	0.16	22.76
operating income	428130000	363772000	17.69
operating income ratio	0.08	0.08	-0.79
net income	399194000	708655000	-43.67
net income ratio	0.08	0.16	-52.52
eps	12.13	21.39	-43.29

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 5,222 million in 2023 from 4,401 million in 2022 representing a change of 18.63%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,883 million in 2023 from 372 million in 2022 representing a change of 406.01%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 1,455 million in 2023 from 8 million in 2022 representing a change of 17206.71%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to 428 million in 2023 from 364 million in 2022 representing a change of 17.69%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 0 million in 2022 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,053 million in 2023 from 1,063 million in 2022 representing a change of -0.87%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 399 million in 2023 from 709 million in 2022 representing a change of -43.67%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 12.13 in 2023 from 12.13 in 2022 representing a change of -43.29%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	2885580000	2793777000	3.29
gross profit	1075710000	345437000	211.41
gross profit ratio	0.37	0.12	201.50
research and development expenses	0	509000	-100.00
operating expenses	878887000	8294000	10496.66
interest income	25048000	19517000	28.34
interest expense	101669000	91964000	10.55
ebitda	516311000	537257000	-3.90
ebitdaratio	0.18	0.19	-6.96
operating income	196823000	337143000	-41.62
operating income ratio	0.07	0.12	-43.48
net income	200411000	228498000	-12.29
net income ratio	0.07	0.08	-15.08
eps	6.13	6.97	-12.05

Overall Score of Quarterly Income Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 2,886 million in 2024Q2 from 2,794 million in 2023Q4 representing a change of 3.29%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,076 million in 2024Q2 from 345 million in 2023Q4 representing a change of 211.41%. This indicates a sales profitability growth, which is a positive sign for the company.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2024Q2 from 1 million in 2023Q4 representing a change of -100.0%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 879 million in 2024Q2 from 8 million in 2023Q4 representing a change of 10496.66%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 516 million in 2024Q2 from 537 million in 2023Q4 representing a change of -3.9%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 197 million in 2024Q2 from 337 million in 2023Q4 representing a change of -41.62%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 200 million in 2024Q2 from 228 million in 2023Q4 representing a change of -12.29%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 6.13 in 2024Q2 from 6.13 in 2023Q4 representing a change of -12.05%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	19020522000	17679712000	7.58
total liabilities	12643459000	11677255000	8.27
total equity	6377063000	6002457000	6.24
cash and cash equivalents	989810000	1160972000	-14.74
short term investments	589953000	544498000	8.35
long term investments	2245107000	8655371000	-74.06
total current assets	6677353000	5645503000	18.28
total non current assets	12343168000	12034208999	2.57
total current liabilities	9840010000	8757920000	12.36
total non current liabilities	2803449000	2919334999	-3.97
common stock	2295000	2295000	0.00
retained earnings	0	4547922000	-100.00
total debt	9668245000	8958866000	7.92

Overall Score of Annual Balance Sheet

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 19,021 million in 2023 from 17,680 million in 2022 representing a change of 7.58%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 6,377 million in 2023 from 6,002 million in 2022 representing a change of 6.24%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 590 million in 2023 from 544 million in 2022 representing a change of 8.35%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 6,677 million in 2023 from 5,646 million in 2022 representing a change of 18.28%. This indicates a better liquidity position.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 12,643 million in 2023 from 11,677 million in 2022 representing a change of 8.27%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 990 million in 2023 from 1,161 million in 2022 representing a change of -14.74%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 9,840 million in 2023 from 8,758 million in 2022 representing a change of 12.36%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 0 million in 2023 from 4,548 million in 2022 representing a change of -100.0%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 9,668 million in 2023 from 8,959 million in 2022 representing a change of 7.92%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	19704913000	19020522000	3.60
total liabilities	13194133000	12643459000	4.36
total equity	6510780000	6377063000	2.10
cash and cash equivalents	1063867999	989810000	7.48
short term investments	629989000	589954000	6.79
long term investments	2271599000	8844383000	-74.32
total current assets	7283371000	6666355000	9.26
total non current assets	12387072000	12354167000	0.27
total current liabilities	10355975000	9840010000	5.24
total non current liabilities	2838158000	2803449000	1.24
common stock	2295000	2295000	0.00
retained earnings	4958811000	4907712000	1.04
total debt	2102498000	9668245000	-78.25

Overall Score of Quarterly Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 19,705 million in 2024Q2 from 19,021 million in 2023Q4 representing a change of 3.6%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 6,511 million in 2024Q2 from 6,377 million in 2023Q4 representing a change of 2.1%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,064 million in 2024Q2 from 990 million in 2023Q4 representing a change of 7.48%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 630 million in 2024Q2 from 590 million in 2023Q4 representing a change of 6.79%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 7,283 million in 2024Q2 from 6,666 million in 2023Q4 representing a change of 9.26%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 4,959 million in 2024Q2 from 4,908 million in 2023Q4 representing a change of 1.04%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 2,102 million in 2024Q2 from 9,668 million in 2023Q4 representing a change of -78.25%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 13,194 million in 2024Q2 from 12,643 million in 2023Q4 representing a change of 4.36%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 10,356 million in 2024Q2 from 9,840 million in 2023Q4 representing a change of 5.24%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-171162000	277242000	-161.74
operating cash flow	651189000	705116000	-7.65
free cash flow	217200000	190586000	13.96
capital expenditure	-433989000	-514530000	15.65
depreciation and amortization	385286000	359585000	7.15
deferred income tax	0	-672821000	100.00
stock based compensation	4818000	-5834000	182.58
accounts payables	259185999	0	NaN
inventory	43719000	-19152000	328.27
acquisitions net	75524000	-27726000	372.39
investments in property plant and equipment	-433989000	-514530000	15.65
net cash used for investing activites	-520823999	-41040000	-1169.06
debt repayment	-90619000	-230626000	60.71
common stock issued	0	0	NaN
common stock repurchased	-59780000	-24211000	-146.91
dividends paid	-102511000	-91085000	-12.54
net cash used provided by financing activities	-302180000	-388929000	22.30
cash at end of period	989810000	1160972000	-14.74
accounts receivables	-1259224000	59667000	-2210.42
cash at beginning of period	1160972000	883730000	31.37

Overall Score of Annual Cashflow Statement

0.22 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -171 million in 2023 from 277 million in 2022 representing a change of -161.74%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 651 million in 2023 from 705 million in 2022 representing a change of -7.65%. This indicates that the company generated less cash from its core business operations.

  Capital Expenditure: Capital Expenditure increased to -434 million in 2023 from -515 million in 2022 representing a change of 15.65%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -673 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 5 million in 2023 from -6 million in 2022 representing a change of 182.58%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 259 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -103 million in 2023 from -91 million in 2022 representing a change of -12.54%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Free Cash Flow: Free Cash Flow increased to 217 million in 2023 from 191 million in 2022 representing a change of 13.96%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Receivables: Accounts Receivables decreased to -1,259 million in 2023 from 60 million in 2022 representing a change of -2210.42%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	585452000	414033000	41.40
free cash flow	405651000	213710000	89.81
capital expenditure	-179801000	-200323000	10.24
depreciation and amortization	212642000	200114000	6.26
deferred income tax	0	-859624000	100.00
stock based compensation	-646000	5465000	-111.82
accounts receivables	-369356000	-482622000	23.47
accounts payables	0	259186000	-100.00
inventory	-14507000	28691000	-150.56
acquisitions net	3276000	41942000	-92.19
investments in property plant and equipment	-179801000	-200323000	10.24
net cash used for investing activites	-254147000	-261125999	2.67
debt repayment	-126365000	-111253000	-13.58
common stock issued	0	0	NaN
common stock repurchased	-2882000	-47962000	93.99
dividends paid	-111301000	0	NaN
net cash used provided by financing activities	-256141000	-186480000	-37.36
net change in cash	1063867999	-31318000	3496.99
cash at end of period	1063867999	989810000	7.48
cash at beginning of period	0	1021128000	-100.00

Overall Score of Quarterly Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 1,064 million in 2024Q2 from -31 million in 2023Q4 representing a change of 3496.99%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 585 million in 2024Q2 from 414 million in 2023Q4 representing a change of 41.4%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 406 million in 2024Q2 from 214 million in 2023Q4 representing a change of 89.81%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to -1 million in 2024Q2 from 5 million in 2023Q4 representing a change of -111.82%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024Q2 from 259 million in 2023Q4 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -180 million in 2024Q2 from -200 million in 2023Q4 representing a change of 10.24%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024Q2 from -860 million in 2023Q4 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Accounts Receivables: Accounts Receivables increased to -369 in 2024Q2 from -483 million in 2023Q4 representing a change of 23.47%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -111 million in 2024Q2 from 0 million in 2023Q4 representing a change of nan%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	158.68	132.86	19.43
net income per share	12.13	21.39	-43.29
operating cash flow per share	19.79	21.28	-7.02
free cash flow per share	6.6	5.75	14.73
cash per share	48.01	51.48	-6.75
book value per share	193.8	181.19	6.96
tangible book value per share	180.46	158.32	13.98
shareholders equity per share	149.33	139.87	6.77
interest debt per share	295.6	272.17	8.61
market cap	5225409597.6	5307063787.8	-1.54
enterprise value	13903844597.6	13104957787.8	6.10
pe ratio	13.09	7.49	74.79
price to sales ratio	1.0	1.21	-17.00
pocfratio	8.02	7.53	6.62
pfcf ratio	24.06	27.85	-13.60
pb ratio	1.06	1.15	-7.16
ptb ratio	1.06	1.15	-7.16
ev to sales	2.66	2.98	-10.57
enterprise value over ebitda	13.2	12.33	7.03
ev to operating cash flow	21.35	18.59	14.88
ev to free cash flow	64.01	68.76	-6.90
earnings yield	0.08	0.13	-42.79
free cash flow yield	0.04	0.04	15.75
debt to equity	1.97	1.93	1.76
debt to assets	0.51	0.51	0.31
net debt to ebitda	8.24	7.34	12.27
current ratio	0.68	0.64	5.27
interest coverage	7.31	6.34	15.42
income quality	1.52	1.0	52.21
dividend yield	0.02	0.02	14.30
payout ratio	0.26	0.13	99.79
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0.02	0.04	-46.14
capex to operating cash flow	0.67	0.73	-8.67
capex to revenue	0.08	0.12	-28.90
capex to depreciation	1.13	1.43	-21.28
stock based compensation to revenue	0.0	-0.0	169.61
graham number	201.9	259.46	-22.19
roic	0.02	0.02	4.85
return on tangible assets	0.02	0.04	-48.70
graham net net	-231.97	-222.56	-4.23
working capital	-3162657000	-3112417000	-1.61
tangible asset value	5938134000	5244902000	13.22
net current asset value	-5966106000	-6031752000	1.09
invested capital	185684000	365846000	-49.25
average receivables	3313515500	3072639000	7.84
average payables	1201508500	1140676500	5.33
average inventory	1059000500	888358500	19.21
days sales outstanding	264.0	236.38	11.68
days payables outstanding	138.51	102.93	34.56
days of inventory on hand	130.77	83.52	56.57
receivables turnover	1.38	1.54	-10.46
payables turnover	2.64	3.55	-25.69
inventory turnover	2.79	4.37	-36.13
roe	0.08	0.15	-46.88
capex per share	13.19	15.53	-15.08

• ROE:

  Debt-to-Equity Ratio:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 13.09 on 2023-12-31 from 7.49 on 2022-12-31, representing a change of 74.79%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio increased to 0.68 on 2023-12-31 from 0.64 on 2022-12-31, representing a change of 5.27%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
ACKB.BR
calendar year	2024	2023	NaN
revenue per share	88.21	85.22	3.52
net income per share	6.13	6.97	-12.09
operating cash flow per share	17.9	12.63	41.72
free cash flow per share	12.4	6.52	90.24
cash per share	51.78	48.19	7.46
book value per share	199.04	194.51	2.33
tangible book value per share	185.61	181.12	2.48
shareholders equity per share	153.49	149.89	2.40
interest debt per share	67.38	297.71	-77.37
market cap	5341720833.7	5206216712	2.60
enterprise value	6380350834.7	13884651712	-54.05
pe ratio	6.66	5.7	16.98
price to sales ratio	1.85	1.86	-0.66
pocfratio	9.12	12.57	-27.44
pfcf ratio	13.17	24.36	-45.95
pb ratio	1.06	1.06	0.42
ptb ratio	1.06	1.06	0.42
ev to sales	2.21	4.97	-55.51
enterprise value over ebitda	12.36	25.84	-52.18
ev to operating cash flow	10.9	33.54	-67.50
ev to free cash flow	15.73	64.97	-75.79
earnings yield	0.04	0.04	-14.52
free cash flow yield	0.08	0.04	85.00
debt to equity	0.42	1.97	-78.72
debt to assets	0.11	0.51	-79.01
net debt to ebitda	2.01	16.15	-87.55
current ratio	0.7	0.68	3.81
interest coverage	1.94	3.67	-47.19
income quality	2.92	1.81	61.22
dividend yield	0.02	0	NaN
payout ratio	0.56	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0.02	0.02	-3.41
capex to operating cash flow	0.31	0.48	-36.52
capex to revenue	0.06	0.07	-13.10
capex to depreciation	0.85	1.0	-15.53
stock based compensation to revenue	-0.0	0.0	-111.44
graham number	145.46	153.31	-5.12
roic	0.01	0.03	-45.87
return on tangible assets	0.01	0.01	-15.41
graham net net	-235.57	-232.83	-1.18
working capital	-3072604000	-3173655000	3.18
tangible asset value	6071545000	5938134000	2.25
net current asset value	-5910762000	-5977104000	1.11
invested capital	275971000	174686000	57.98
average receivables	4270740500	3599602000	18.64
average payables	1379387500	1216218000	13.42
average inventory	818784500	1128630000	-27.45
days sales outstanding	148.61	121.66	22.15
days payables outstanding	74.19	46.57	59.33
days of inventory on hand	21.96	43.96	-50.06
receivables turnover	0.61	0.74	-18.14
payables turnover	1.21	1.93	-37.24
inventory turnover	4.1	2.05	100.22
roe	0.04	0.05	-14.16
capex per share	5.5	6.11	-10.04

• Negative

  ROE: Return on Equity (ROE) decreased to 0.04 on 2024-06-30 Q2 from 0.05 on 2023-12-31 Q4, representing a change of -14.16%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 0.70 on 2024-06-30 Q2 from 0.68 on 2023-12-31 Q4, representing a change of 3.81%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 6.66 on 2024-06-30 Q2 from 5.70 on 2023-12-31 Q4, representing a change of 16.98%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.42 on 2024-06-30 Q2 from 1.97 on 2023-12-31 Q4, representing a change of -78.72%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 52.35 which is lower than current price 187.6, indicates the company may be overvalued.